What is the address of K-THERAPY?

The registered office of K-THERAPY is located at Stallestraat 63/B, 1180 Ukkel.

Is K-THERAPY still active?

Yes. According to the CBE (2 October 2026) K-THERAPY is active, legal situation “Normale toestand”, started on 2 April 2021.

Is K-THERAPY registered on Peppol?

Yes, K-THERAPY is registered on the Peppol network with ID 0208:0766321279.

What is the enterprise number of K-THERAPY?

The enterprise number of K-THERAPY is BE0766321279.

When was K-THERAPY founded?

K-THERAPY was founded on 2 April 2021.

Is K-THERAPY a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 April 2021; 5 annual accounts filed, latest fiscal year 2025.

How much profit did K-THERAPY make in 2025?

K-THERAPY posted a profit after taxes of € 7,116 in financial year 2025.

What is the revenue of K-THERAPY?

As a small company, K-THERAPY is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 37,763.

K-THERAPY (Private Limited) - Ukkel - BE0766321279

Dossier K-THERAPY, printed on 2 October 2026 from databakkes.be/en/0766321279/k-therapy. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 62 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

K-THERAPY from Ukkel, company number BE0766321279, closed financial year 2025 with a result of € 7,116 after tax. For that financial year K-THERAPY recorded a gross margin of € 37,763 and equity of € 40,162. Compared with financial year 2024, the result moved from € -3,938 to € 7,116. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on May 26, 2026.

What it is worth Growing

€ 40,162

▲ 22% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 7,116

▲ still € 3,938 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 9,652

▲ 86% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 35,162.

People and assets in 2025

Vehicles and equipment

€ 1,985

▼ 60% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 15 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 283,208

▼ 6% vs 2024

€ 18,987 is repaid this year. At this pace the long-term loan is gone in ≈ 15 years.

Owed to suppliers

€ 251

▲ € 245 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 52,889 Gross margin 2022: € 52,889 First fiscal year in the series	€ 52,659 Gross margin 2023: € 52,659 Unchanged (€ 52,889) Unfavourable step	€ 30,629 Gross margin 2024: € 30,629 ▼ 42% vs 2023 (€ 52,659) Unfavourable step	€ 37,763 Gross margin 2025: € 37,763 ▲ 23% vs 2024 (€ 30,629) Favourable step	▲ 23%
Profit after taxes	€ 26,779 Profit after taxes 2022: € 26,779 First fiscal year in the series	€ 24,130 Profit after taxes 2023: € 24,130 ▼ 10% vs 2022 (€ 26,779) Unfavourable step	€ -3,938 Profit after taxes 2024: € -3,938 ▼ € 28,068 vs 2023 (€ 24,130) Unfavourable step	€ 7,116 Profit after taxes 2025: € 7,116 ▲ € 11,054 vs 2024 (€ -3,938) Favourable step	▲ € 11,054
Equity	€ 12,853 Equity 2022: € 12,853 First fiscal year in the series	€ 36,983 Equity 2023: € 36,983 ▲ 188% vs 2022 (€ 12,853) Favourable step	€ 33,045 Equity 2024: € 33,045 ▼ 11% vs 2023 (€ 36,983) Unfavourable step	€ 40,162 Equity 2025: € 40,162 ▲ 22% vs 2024 (€ 33,045) Favourable step	▲ 22%
Total debts	€ 337,756 Total debts 2022: € 337,756 First fiscal year in the series	€ 307,768 Total debts 2023: € 307,768 ▼ 9% vs 2022 (€ 337,756) Favourable step	€ 311,674 Total debts 2024: € 311,674 ▲ 1% vs 2023 (€ 307,768) Unfavourable step	€ 285,498 Total debts 2025: € 285,498 ▼ 8% vs 2024 (€ 311,674) Favourable step	▼ 8%
Cash	€ 16,608 Cash 2022: € 16,608 First fiscal year in the series	€ 20,918 Cash 2023: € 20,918 ▲ 26% vs 2022 (€ 16,608) Favourable step	€ 5,187 Cash 2024: € 5,187 ▼ 75% vs 2023 (€ 20,918) Unfavourable step	€ 9,652 Cash 2025: € 9,652 ▲ 86% vs 2024 (€ 5,187) Favourable step	▲ 86%
Land & buildings	€ 238,236 Land & buildings 2022: € 238,236 First fiscal year in the series	€ 232,055 Land & buildings 2023: € 232,055 ▼ 3% vs 2022 (€ 238,236) Unchanged	€ 262,266 Land & buildings 2024: € 262,266 ▲ 13% vs 2023 (€ 232,055) Unchanged	€ 254,962 Land & buildings 2025: € 254,962 ▼ 3% vs 2024 (€ 262,266) Unchanged	▼ 3%
Retained profit	€ 7,853 Retained profit 2022: € 7,853 First fiscal year in the series	€ 31,983 Retained profit 2023: € 31,983 ▲ € 24,130 vs 2022 (€ 7,853) Favourable step	€ 28,045 Retained profit 2024: € 28,045 ▼ 12% vs 2023 (€ 31,983) Unfavourable step	€ 35,162 Retained profit 2025: € 35,162 ▲ 25% vs 2024 (€ 28,045) Favourable step	▲ 25%
Bank debt	€ 301,872 Bank debt 2022: € 301,872 First fiscal year in the series	€ 287,643 Bank debt 2023: € 287,643 ▼ 5% vs 2022 (€ 301,872) Favourable step	€ 301,850 Bank debt 2024: € 301,850 ▲ 5% vs 2023 (€ 287,643) Unfavourable step	€ 283,208 Bank debt 2025: € 283,208 ▼ 6% vs 2024 (€ 301,850) Favourable step	▼ 6%
Balance sheet total	€ 350,609 Balance sheet total 2022: € 350,609 First fiscal year in the series	€ 344,751 Balance sheet total 2023: € 344,751 ▼ 2% vs 2022 (€ 350,609) Unchanged	€ 344,719 Balance sheet total 2024: € 344,719 Unchanged (€ 344,751) Unchanged	€ 325,659 Balance sheet total 2025: € 325,659 ▼ 6% vs 2024 (€ 344,719) Unchanged	▼ 6%

Key figures of K-THERAPY, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to K-THERAPY?

What happened at K-THERAPY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 26, 2026 New annual accounts for financial year 2025: profit of € 7,116. Source: NBB ↗
Apr 2, 2021 New establishment in Ukkel. KBO
Apr 2, 2021 Start of the company according to the CBE. KBO

In short

From € 26,779 profit in 2022 to € 7,116 profit in 2025.

Paid € 3,454 in corporate taxes since 2022.

Best year ever: 2022, with € 26,779 profit.

Original PDFs at the National Bank ↗

A new publication or filing at K-THERAPY? We notify you, reason included.

Follow K-THERAPY

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Establishments

Establishment units

Physical locations of this company

Registered office

Stallestraat 63/B

1180 Ukkel

2.315.621.216

Stallestraat 63 box B

1180 Ukkel

Active since 2 April 2021

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0766.321.279
VAT number: BE 0766.321.279
Registered office: Stallestraat 63/B, 1180 Ukkel
Names & denominations: K-THERAPY
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 2 April 2021
Peppol: Active · Active since 30 Dec 2025

View on CBE Public ↗ Annual accounts (NBB) ↗

K-THERAPY